In the last trading session, 3.99 million shares of the Charles River Laboratories International Inc (NYSE:CRL) were traded, and its beta was 1.58. Most recently the company’s share price was $106.60, and it changed around $6.85 or 6.87% from the last close, which brings the market valuation of the company to $5.24B. CRL currently trades at a discount to its 52-week high of $254.15, offering almost -138.41% off that amount. The share price’s 52-week low was $91.86, which indicates that the current value has risen by an impressive 13.83% since then. We note from Charles River Laboratories International Inc’s average daily trading volume that its 10-day average is 3.26 million shares, with the 3-month average coming to 1.51 million.
Charles River Laboratories International Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.90. If we narrow it down even further, the data shows that 1 out of 21 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 16 recommended CRL as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Charles River Laboratories International Inc is expected to report earnings per share of 2.08 for the current quarter.
Charles River Laboratories International Inc (NYSE:CRL) trade information
Instantly CRL has showed a green trend with a performance of 6.87% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 139.31 on recent trading dayincreased the stock’s daily price by 23.48%. The company’s shares are currently down -42.25% year-to-date, but still down -20.49% over the last five days. On the other hand, Charles River Laboratories International Inc (NYSE:CRL) is -37.68% down in the 30-day period. We can see from the shorts that 2.66 million shares have been sold at a short interest cover period of 2.13 day(s).
The consensus price target as assigned by Wall Street analysts is $205, which translates to bulls needing to increase their stock price by 48.0% from its current value. Analyst projections state that CRL is forecast to be at a low of $205 and a high of $205.
Charles River Laboratories International Inc (CRL) estimates and forecasts
The year-over-year growth rate is expected to be -5.57%, down from the previous year.
Consensus estimates provided by 12 financial analysts predict the company will bring in an average of 941.53M in revenue for the current quarter. 12 analysts expect Charles River Laboratories International Inc to make 959.4M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 1.01B and 1.03B respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -6.92%. Forecasts for the next quarter put sales growth at -6.50%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -47.65%. Charles River Laboratories International Inc earnings are expected to increase by -9.70% in 2025, but the outlook is positive 2.58% per year for the next five years.
CRL Dividends
Charles River Laboratories International Inc’s next quarterly earnings report is expected to be released on 2025-Feb-18.
Charles River Laboratories International Inc (NYSE:CRL)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.88% of Charles River Laboratories International Inc shares, and 110.14% of them are in the hands of institutional investors. The stock currently has a share float of 111.12%. Charles River Laboratories International Inc stock is held by 919.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 11.8396% of the shares, which is about 6.1 million shares worth $1.26 billion.
BLACKROCK INC., with 9.8699% or 5.09 million shares worth $1.05 billion as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Jan 31, 2025 . The former held 2.0 shares worth $213.11 million, making up 4.07% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 1.6 shares worth around $170.4 million, which represents about 3.25% of the total shares outstanding.
